Robert D. McBane

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

Stephen E. Kimmel, Benjamin French, Scott E. Kasner et al. · New England Journal of Medicine · 2013 · 741 citations · Full text

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar et al. · New England Journal of Medicine · 2019 · 683 citations · Full text

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane, Waldemar E. Wysokiński, Jennifer Le‐Rademacher et al. · Journal of Thrombosis and Haemostasis · 2019 · 554 citations

Thrombosis, Venous Thrombosis, Adam Vte Trial +6

The United States Registry for Fibromuscular Dysplasia

Jeffrey W. Olin, James B. Froehlich, Xiaokui Gu et al. · Circulation · 2012 · 533 citations

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Xiaoxi Yao, Neena S. Abraham, Lindsey R. Sangaralingham et al. · Journal of the American Heart Association · 2016 · 411 citations · Full text